| Literature DB >> 31663122 |
Farzad Rahmani1, Aghigh Ziaeemehr2, Soodabeh Shahidsales3, Masoumeh Gharib4, Majid Khazaei5, Gordon A Ferns6, Mikhail Ryzhikov7, Amir Avan8,9, Seyed M Hassanian1,8.
Abstract
Hepatocellular carcinoma (HCC) is one of the common malignant human tumors with high morbidity worldwide. Aberrant activation of the oncogenic phosphoinositide 3-kinase/protein kinase B/mammalian target of rapamycin (PI3K/AKT/mTOR) signaling is related to clinicopathological features of HCC. Emerging data revealed that microRNAs (miRNAs) have prominent implications for regulating cellular proliferation, differentiation, apoptosis, and metabolism through targeting the PI3K/AKT/mTOR signaling axis. The recognition of the crucial role of miRNAs in hepatocarcinogenesis represents a promising area to identify novel anticancer therapeutics for HCC. The present study summarizes the major findings about the regulatory role of miRNAs in the PI3K/AKT/mTOR pathway in the pathogenesis of HCC.Entities:
Keywords: PI3K/AKT/mTOR pathway; hepatocellular carcinoma; microRNA
Mesh:
Substances:
Year: 2019 PMID: 31663122 DOI: 10.1002/jcp.29333
Source DB: PubMed Journal: J Cell Physiol ISSN: 0021-9541 Impact factor: 6.384